CDXI — Cardax Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.34m
- $0.54m
Annual cashflow statement for Cardax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.78 | -1.99 | -4.02 | -5.09 | -5.06 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.231 | 0.242 | 0.74 | 1.51 | 2.18 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.267 | -0.367 | 0.053 | 0.022 | 1.05 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.26 | -2.08 | -3.2 | -3.52 | -1.79 |
| Other Investing Cash Flow Items | -0.029 | -0.019 | -0.037 | -0.062 | -0.015 |
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.029 | -0.019 | -0.037 | -0.062 | -0.015 |
| Financing Cash Flow Items | — | — | — | — | -0.04 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.12 | 4.18 | 1.24 | 3.36 | 1.81 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.165 | 2.08 | -1.99 | -0.224 | -0 |